Form 8-K - Current report:
SEC Accession No. 0001193125-24-061288
Filing Date
2024-03-07
Accepted
2024-03-07 06:06:32
Documents
16
Period of Report
2024-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d764812d8k.htm   iXBRL 8-K 26358
2 EX-99.1 d764812dex991.htm EX-99.1 70702
6 GRAPHIC g764812g0307082415750.jpg GRAPHIC 2696
  Complete submission text file 0001193125-24-061288.txt   233260

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA slno-20240306.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE slno-20240306_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slno-20240306_pre.xml EX-101.PRE 11260
18 EXTRACTED XBRL INSTANCE DOCUMENT d764812d8k_htm.xml XML 3672
Mailing Address 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065
Business Address 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Filer) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36593 | Film No.: 24728028
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)